Clinical Trial Update: Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination

View source ↗

Summary

Clinical trial update noting continuation of drug supply for Chinese patients after termination of CAMN107DBR01 in Gastrointestinal Stromal Tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Gastrointestinal Stromal Tumor | Status: NO_LONGER_AVAILABLE